1 domain / 1 area / 1 specialization
Founders Fund
Also known as: Founders Fund, LLC
Data updated
Founders Fund is a generalist venture capital firm known for backing large, category-defining technology companies across sectors. Its public positioning is broad rather than healthcare-specific, and the firm is not publicly organized around psychedelic medicine.
Its relevance to psychedelic medicine comes from participation in COMPASS Pathways' 2020 Series B round. That makes Founders Fund a meaningful crossover investor in a landmark psilocybin drug developer, but not a dedicated psychedelic investor.
Investor Context
Venture CapitalInvestment Context
This stakeholder is listed as a Venture Capital Fund within Venture Capital. Its public geography context is global. Public stage signals include Multi-Stage. Public focus areas include Drug Development and Digital Therapeutics & Platforms.
Public Portfolio Examples
- COMPASS PathwaysSeries B - $80m - Apr 27, 2020
Founders Fund represents broad technology venture capital with a confirmed COMPASS Pathways investment. The record is useful for mapping crossover capital into psychedelic drug development, while keeping clear that the firm does not present a public psychedelic-focused strategy.
Investor Type
Venture Capital Fund
Geographic Scope
Global
Psychedelic Focus
No Public Psychedelic Focus
Engagement
Monitoring-Only
Investment Stage Focus
Investment Focus Areas
Investment Orientation
Engagement Status
Monitoring-Only
Investor Type
Venture Capital Fund
Portfolio Stakeholders
Recorded Investments
Apr 27, 2020
Series B - $80m
Direct psychedelic medicine financing record in a landmark psilocybin drug developer.
Mental health care company COMPASS Pathways concludes successful Series B investment roundQuick Facts
- Founded
- 2005
- HQ
- San Francisco, California, United States
- Website
- Visit